Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILUZOLE vs RISDIPLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILUZOLE vs RISDIPLAM: Safety Overview

Metric RILUZOLE RISDIPLAM
Total FAERS Reports 1,437 3,619
Deaths Reported 342 336
Death Rate 23.8% 9.3%
Hospitalizations 264 719
Average Patient Age 63.5 yrs 21.8 yrs
% Female Patients 47.5% 55.2%
FDA Approval Date Aug 22, 2024 Aug 7, 2020
Manufacturer EDW PHARMA Genentech, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription